A Case of Epstein-Barr Virus-Associated Extranodal NK/T-Cell Lymphoma Developing 16 Years After Kidney Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1043; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He had received tacrolimus, methylprednisolone, and mizoribine...Although the lesion was initially suspected to represent B-cell PTLD, disease progression occurred despite rituximab therapy, and repeat biopsy established the diagnosis of ENKTL. Late-onset PTLD may exhibit more diverse and complex histopathological features compared with early-onset PTLD. Repeated pathological evaluation should be considered in refractory or progressive lesions after transplantation."
Clinical • Epstein-Barr Virus Infections • Extranodal Natural Killer/T-cell Lymphoma • Glomerulonephritis • Hematological Malignancies • Infectious Disease • Lupus Nephritis • Lymphoma • Natural Killer/T-cell Lymphoma • Nephrology • Otorhinolaryngology • Renal Disease • Solid Organ Transplantation • T Cell Non-Hodgkin Lymphoma • Transplantation • CD20 • IL2 • NCAM1
|
|
Sakura Shimizu; Kaori Yamaguchi; Tomoaki Funamoto; Yasuyuki Shinozaki; Misaki Yoshida; Akihiko Koshino; Keisuke Sako; Takahiro Yuasa; Taichiro Minami; Ryo Nishioka; Megumi Oshima; Yuta Yamamura; Satoshi Hara; Kiyoaki Ito; Ichiro Mizushima; Norihiko Sakai; Yasunori Iwata
|